TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Not Specified
CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference

CG Oncology announced that its Chairman & CEO Arthur Kuan and President & COO Ambaw Bellete will present at the 44th Annual J.P. Morgan Healthcare Conference on January 15, 2026. The company is a late-stage clinical biopharmaceutical firm developing bladder-sparing therapeutics for bladder cancer patients, with recent data showing promising efficacy rates for its lead candidate cretostimogene grenadenorepvec in non-muscle invasive bladder cancer.

Insights
AAPL   positive

Thiel significantly increased holdings by purchasing 79,181 shares, showing confidence in the company's future


CGON   positive

The company is presenting at a major healthcare conference and has announced promising clinical data showing high efficacy rates (95.7% at 3-months, 84.6% at 6-months, 80.4% at 9-months) for its lead therapeutic candidate in high-risk bladder cancer patients, indicating progress in late-stage development.